10x Genomics to Report First Quarter Financial Results on May 4, 2022
04/07/2022 - 04:05 PM
PLEASANTON, Calif. April 7, 2022 Wednesday, May 4, 2022 . The company's management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook.
Live audio of the webcast will be available on the "Investors" section of the company website at: www.10xgenomics.com . The webcast will be archived and available for replay for at least 45 days after the event.
About 10x Genomics
10x Genomics is a life science technology company building products to interrogate, understand and master biology to advance human health. The company's integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. 10x Genomics products have been adopted by researchers around the world including in all of the top 100 global research institutions as ranked by Nature in 2020 based on publications and all of the top 20 global pharmaceutical companies by 2020 research and development spend and have been cited in over 3,300 research papers on discoveries ranging from oncology to immunology and neuroscience. The company's patent portfolio comprises more than 1,300 issued patents and patent applications.
Disclosure Information
10x Genomics uses filings with the Securities and Exchange Commission, its website (www.10xgenomics.com ), press releases, public conference calls, public webcasts and its social media accounts as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.
Media Contact: media@10xgenomics.com
Investor Relations Contact: investors@10xgenomics.com
https://www.prnewswire.com/news-releases/10x-genomics-to-report-first-quarter-financial-results-on-may-4-2022-301520307.html
SOURCE 10x Genomics, Inc.
10x Genomics Inc
NASDAQ:TXG
TXG Rankings
#596 Ranked by Stock Gains
TXG Stock Data
Industry
Testing Laboratories
Sector
Professional, Scientific, and Technical Services
Tags
Commercial Services, Miscellaneous Commercial Services, Health Technology, Biotechnology, Professional, Scientific, and Technical Services, Testing Laboratories
Country
US
City
Pleasanton
About TXG
advancing human health requires a greater understanding of biology, and that understanding starts with the cell. we enable researchers to drive exponential progress in oncology, immunology, neuroscience, and more with novel single cell, spatial, and in situ tools that have been cited in over 3,000 publications and continually improved by our dedicated scientific team. our aim: to develop innovative instruments, reagents, and software that allow you to see your biological system at a resolution that matches its complexity.
